Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database
Go back to Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database| (NASDAQ: IMDX) | Delayed: 4.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.43 | 52 Week High | $ | |||
| Open | $4.43 | 52 Week Low | $ | |||
| Day High | $4.43 | P/E | N/A | |||
| Day Low | $4.43 | EPS | $ | |||
| Volume | 292 | |||||

